Acelyrin Statistics
Share Statistics
Acelyrin has 100.33M shares outstanding. The number of shares has increased by 2.54% in one year.
| Shares Outstanding | 100.33M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.79% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 73.18M |
| Failed to Deliver (FTD) Shares | 1.34K |
| FTD / Avg. Volume | 0.19% |
Short Selling Information
The latest short interest is 4.70M, so 4.71% of the outstanding shares have been sold short.
| Short Interest | 4.70M |
| Short % of Shares Out | 4.71% |
| Short % of Float | 6.47% |
| Short Ratio (days to cover) | 8.01 |
Valuation Ratios
The PE ratio is -1.37 and the forward PE ratio is -2.8.
| PE Ratio | -1.37 |
| Forward PE | -2.8 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0.8 |
| P/FCF Ratio | -2.88 |
| PEG Ratio | n/a |
Enterprise Valuation
Acelyrin Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 8.65, with a Debt / Equity ratio of 0.
| Current Ratio | 8.65 |
| Quick Ratio | 8.65 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.58% and return on capital (ROIC) is -64.19%.
| Return on Equity (ROE) | -0.58% |
| Return on Assets (ROA) | -0.51% |
| Return on Capital (ROIC) | -64.19% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -2.83M |
| Employee Count | 135 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -59.01% in the last 52 weeks. The beta is 0, so Acelyrin 's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | -59.01% |
| 50-Day Moving Average | 5.18 |
| 200-Day Moving Average | 5.28 |
| Relative Strength Index (RSI) | 23.33 |
| Average Volume (20 Days) | 720.13K |
Income Statement
In the last 12 months, Acelyrin had revenue of $0 and earned -$381.64M in profits. Earnings per share was $-5.43.
| Revenue | 0 |
| Gross Profit | -115.00K |
| Operating Income | -422.06M |
| Net Income | -381.64M |
| EBITDA | -381.53M |
| EBIT | - |
| Earnings Per Share (EPS) | -5.43 |
Balance Sheet
The company has $218.10M in cash and $1.19M in debt, giving a net cash position of $216.90M.
| Cash & Cash Equivalents | 218.10M |
| Total Debt | 1.19M |
| Net Cash | 216.90M |
| Retained Earnings | -488.72M |
| Total Assets | 618.31M |
| Working Capital | 513.12M |
Cash Flow
In the last 12 months, operating cash flow was -$169.71M and capital expenditures -$12.29M, giving a free cash flow of -$182.00M.
| Operating Cash Flow | -169.71M |
| Capital Expenditures | -12.29M |
| Free Cash Flow | -182.00M |
| FCF Per Share | -2.59 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
SLRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -168.11% |
| FCF Yield | -56.25% |
Analyst Forecast
The average price target for SLRN is $10.5, which is 225.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.5 |
| Price Target Difference | 225.1% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | 0.06 |
| Piotroski F-Score | 2 |